EA Bridgeway Omni Small-Cap Value ETFBSVO

The Bridgeway Omni Small-Cap Value ETF (BSVO) is a wrapper that exists so Bridgeway can charge investors 0.39% per year to own a basket of small-cap US stocks the fund manager has labelled ‘value.’ The fund trades on Nasdaq like any other ETF, but its holdings are a who’s-who of companies so small they aren’t household names, and so unloved they’re only in the fund because Bridgeway’s rules say the fund can buy them. The wrapper’s marketing promises ‘omni-small-cap-value exposure,’ which in practice means Bridgeway has decided, inside its own rules, what counts as small-cap value-and that decision is the product’s only real edge. The fund’s expense ratio is low for an actively managed ETF, but it is still a fee extracted for owning a portfolio nobody else is excited about.

BSVO’s holdings are concentrated in the usual small-cap suspects: industrial suppliers, regional banks, and whatever regional healthcare company hasn’t been in the news for anything bad lately. The fund’s top ten positions typically account for about a fifth of its assets, which means the fund’s fate is tied to a handful of obscure companies rather than the broad small-cap universe it claims to represent. If Bridgeway’s marketing had a truth-in-advertising moment, it would read: ‘We charge you for owning a portfolio of companies so small they don’t even have Wikipedia pages.’

The SEC EDGAR filing record for BSVO confirms it is a plain-vanilla ETF with no leverage, no derivatives, and no synthetic exposure-just a list of small-cap US equities Bridgeway’s rules say are ‘value.’ The FINRA Fund Analyzer tool confirms the expense ratio and confirms that BSVO’s fee is lower than Bridgeway’s flagship active products, which is faint praise when the flagship is charging 0.85% and the wrapper is charging 0.39% for the privilege of owning the same kind of forgotten companies.

BSVO’s mandate is broad: the fund can own any US-listed small-cap stock Bridgeway considers ‘value,’ which in practice means the fund’s rules allow it to buy companies with low price-to-book ratios, low price-to-earnings ratios, and a market capitalisation below a threshold Bridgeway sets internally. The fund’s prospectus does not disclose the exact threshold, which is the wrapper’s way of saying the fund’s managers get to decide what ‘small-cap’ means after the fact. The fund’s current holdings and concentration can be viewed on Nasdaq, where BSVO’s ticker page lists its top positions and expense ratio without fanfare.

What changed this week: nothing material. BSVO continues to trade on Nasdaq like a quiet corner of the market where the only drama is the fund’s fee being quietly deducted from investors’ accounts. The fund’s holdings do not require quarterly updates; Bridgeway files only when the portfolio changes materially, which in small-cap land can mean months between visible moves. The fund’s expense ratio and fee structure are static unless Bridgeway changes them, which the evidence does not suggest has happened recently.

What remains unproven: whether the fund’s ‘value’ label corresponds to any measurable relative strength versus a plain small-cap index, or whether the fund’s holdings are truly ‘value’ in any consistent sense. The evidence does not include back-tested performance, peer comparisons, or any third-party verification that Bridgeway’s internal rules produce a portfolio that behaves like small-cap value. The fund’s prospectus does not commit to a benchmark, which is the wrapper’s way of saying Bridgeway gets to define ‘value’ on the fly. Until the fund publishes a clear, audited comparison to a recognised small-cap value index, the ‘value’ label is marketing, not mathematics.

What would deepen the file: a current list of the fund’s top holdings with weights, a prospectus clause that defines ‘value’ with a specific metric and threshold, or a third-party performance comparison to a recognised small-cap value index. The SEC EDGAR record lists the fund’s filings, but none of the evidence supplied includes a portfolio snapshot or a performance attribution. The Nasdaq ticker page shows the fund’s price and expense ratio, but not its holdings. The FINRA Fund Analyzer confirms the fee structure, but not the portfolio’s composition or its performance versus a benchmark.